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Abstract
Background: Cerebral vasospasm (CVS) after subarachnoid hemorrhage (SAH) is a serious and significant health
problem in the worldwide. There are still no effective therapies for treatment of CVS in patients suffering from SAH.
Our early studies have demonstrated that the expression of connexin43 (Cx43, a member of gap junctional
proteins) in cerebral spastic vessel is significantly up-regulated, and knocking down Cx43 with specific siRNA
interference can significantly alleviate CVS after SAH. Therefore, Cx43 in cerebral vessel is a potential target in the
treatment of CVS. However, Cx43 is widely distributed in many organs, particularly in the heart, and plays an
important role in the physiological function. This study is aimed at identify whether OPN, TNC or E-selectin can be
used as a target protein to be recognized in spastic cerebral vessels, then we can produce a carrier containing Cx43
siRNA or other inhibitors as a new potential treatment for CVS.
Methods: Twenty eight male Sprague Dawley rats (weighing 300–350 g) were randomly divided into either SAH
(n = 16) or sham group (n = 12). The double hemorrhage model was performed on day 0 and 1. All animals were
sacrificed after performing India ink angiography on day 5. Initially, the expression of E-selectin, TNC and OPN in
cerebral arteries, thoracic aorta and abdominal aorta were analyzed respectively by immunohistochemical staining,
western blot in both groups. Then, only those with less expression in thoracic aorta, abdominal aorta and normal
cerebral arteries, but higher expression in cerebral spastic arteries were further detected in the spinal cord, heart,
kidney, liver, spleen, lung, pancreas, mesenteric and pulmonary arteries, retina and brain tissue, respectively.
Results: TNC, OPN and E-selectin were markedly elevated in the spastic cerebral arteries in SAH group but not in
control group. The expression of TNC, but not OPN and E-selectin, is abundant in both groups of thoracic aorta and
abdominal aorta. Further study demonstrated that expression of OPN, but not E-selecting, in both groups is
relatively rich in brain tissue, kidney, pancreas, mesenteric artery, spinal cord and retina, but in heart, liver, lung and
pulmonary artery. However, the positive expression of E-selectin was detected in spleen in both groups.
Conclusions: TNC is highly expressed in thoracic aorta and abdominal aorta, so it is unsuitable for being a
recognition protein. Although OPN, unlike TNC, does not express much in vascular system, but it expresses in many
other organs or tissues. However, E-selecting could be considered as a potential recognition protein because it is
not so widely distributed in the organs or tissues detected.
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Background
SAH has a high incidence and poor prognosis. Thirty to
sixty percent of these patients may suffer from cerebral
vasospasm (CVS), which may result in cerebral ischemia
and lead to disability or death [1]. There are a large
number of studies relevant to CVS, the technique of
microsurgical and vascular surgery were constantly de-
veloped and updated. However, the exact pathophysi-
ology process of CVS after SAH is still unclear and
therefore there are still no efficient and effective treat-
ment for CVS.
Our early studies have demonstrated that expression
of connexin43 (Cx43, a member of gap junctional pro-
teins) in cerebral spastic vessel is significantly up-
regulated, and knocking down Cx43 with specific siRNA
interference can significantly alleviate CVS after SAH.
Therefore, Cx43 in cerebral vessel is a potential target in
the treatment of CVS. However, Cx43 is widely distrib-
uted in many organs, particularly in the heart, and plays
an important role in the physiological function. In order
to block the over-expressed Cx43 in cerebral vascular
wall after SAH specifically, we tried to find other targets
which only express in the cerebral spastic vessel, but
relatively lower in other organs or tissues.
The object of this study is a target protein screen in
cerebral spastic artery which can be used as a specific
recognition protein and a target to be recognized. In our
next study, we can use this specific target to produce a
carrier (such as nanoparticle) which contains Cx43
siRNA or other inhibitors as a new potential treatment
for CVS.
The blood clots around the cerebral artery can lead to
releasing of various vasoactive and pro-inflammatory
factors which may cause structural and morphological
changes including swelling of smooth muscle cell,
shrinkage, hyperplasia and degeneration of vacuolar, ne-
crosis, infiltration of inflammatory cell in the spastic
cerebral vascular wall [2, 3]. During the pathological
process of cerebral arteries, media layer (mainly contain-
ing SMCs and extracellular matrix) are exposed to the
molecular existing in blood, such as neurotransmitter,
toxin, drugsand so on [4–7].
Osteopontin (OPN) and Tenascin-C (TNC) secrete
extracellular matrix (ECM) glycoproteins, and they
perform their functions when they are tied to cell sur-
face receptor, other matrix proteins, cytokines and
growth factors. The function of matrix protein is regulat-
ing interactions of cell between cell and cell between
matrix. During the physiological status, they are barely
expressed in mature tissues. However, during the inflam-
mation response, the expression of OPN and TNC are
significantly increased. Many studies have showed that
matrix protein played an important role in inflammatory
response [8–10]. E-selectin is a kind of glycoprotein
whose molecular weight is 115KD, which exists in endo-
thelial cells. Pro-inflammatory cytokines such as inter-
leukin, tumor necrosis factor and interferon have
stimulatory effects on the synthesis of E-selectin [11].
Studies have revealed that cerebrovascular endothelial
cells under normal condition barely have expression of
E-selectin. Serum concentration of E-selectin in patients
suffering from CVS has no significant change, but in-
creased rapidly in vascular endothelial cells [12]. So, we
considered that they might be suitable as target recogni-
tion protein.
When CVS occurs after SAH, cerebral vessel will suf-
fer from constant inflammatory response, the drug can
easily recognize the elevated expressed target protein
and specifically knock down Cx43 of SMCs in spastic
cerebral arteries to alleviate CVS after SAH.
Methods
All procedures were approved by the Animal Ethics
Review Committee of Nanchang University and were in
accordance with the institution’s Guidelines for Animal
Experiments.
Animals and experimental groups
Adult male SD rats (weighing 300–350 g) were provided
by the Laboratory Animal Center of Medical College of
Nanchang University and housed in an air-filtered unit
with free access to food, water is under a 12-h light/dark
cycle. The temperature in the feeding room and the op-
eration room was between 22 °C and 25 °C. The animals
were randomly assigned to two groups: (1) sham group
(n = 12), (2) SAH group (n = 12), fresh autologous caudal
artery blood (0.3 ml) was injected into the cisterna
magna of SD rats.
Induction of experimental SAH
Rats were anesthetized with an intraperitoneal injection
of 10 % chloral hydrate (300 mg/kg). In the prone
position of the rat, the atlanto-occipital membrane was
exposed. After the animal was turned into a supine pos-
ition, fresh autologous non-heparinized blood (0.3 ml)
withdrawned from caudal artery. The fixed animal which
in a stereotactic frame and a 25-gauge needle was
inserted through the atlanto-occipital membrane into
the cisterna magna. Then, the 0.1 ml of cerebrospinal
fluid (CSF) was slowly withdrew and the autologous
blood was injected into the cisterna magna at a speed of
0.15 ml/min. After the injection, the animal was placed
at an angle of 30° in head-down position for about
30 min in order to facilitate the blood settle around the
BA. The same procedure was repeated 24 h later with a
0.3 ml fresh autologous blood injection. Shan-operated
rats underwent the same procedure without the blood
injection.
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India ink angiography
Gelatin-India ink solution was made by dissolving
gelatin powder (7 g) in 100 ml PBS mixed with 100 ml
India ink. The ascending aorta was cannulated with a
blunted 20-gauge needle attached to flexible plastic tub-
ing, which was connected to a syringe on a micro pump.
After an incision made in the right atrium which allowed
the outflow of perfusion solutions, 100 ml of PBS,
15 min of 10 % formalin, and 10 min of 3.5 % gelatin-
India ink solution were infused through the closed cir-
cuit. All perfusates were passed through a 0.2-μm pore
size filter. The rat was refrigerated at 4 °C for 24 h to
allow gelatin solidification. The brains were harvested
and high-resolution pictures of the circle of Willis and
basilar arteries (BAs) were taken with a scale before and
after the removal of a subarachnoid clot. The brain was
stored in 10 % neutral buffered formalin. An experienced
person who was unaware of the treatment group mea-
sured the smallest lumen diameter of BA, used Image J
software for three times and determined a mean value
per segment.
H&E staining
After five days, the second hemorrhage rat was perfused
with PBS. The brainstem containing BA was immedi-
ately removed and post-fixed in the 4 % paraformalde-
hyde (PFA) 100 ml for 24 h. The entire length of BA was
divided into proximal, middle, and distal. After it dis-
sected, the middle section was deparaffinized, hydrated,
washed, and stained with Hematoxy-lin-eosin (H & E)
staining.
Immunohistochemical staining
Transections of rats organs were processed into paraffin
blocks, and were cut into 10-μm slices. After deparaffi-
nized, the slices were heated and boiled for 15 min in
citrate buffer solution (0.01 M, PH = 6.0) for retrieval
antigen. Each section was treated with 3 % hydrogen
peroxide for 20 min at room temperature and was used
to diminish nonspecific staining. After rinsing with PBS,
the slices were blocked with 5 % normal goat serum in
PBS (0.01 M, PH = 7.4) for 20 min at room temperature.
The slices were incubated overnight at 4 °C with the
Rabbit Anti-osteopontin antibody (bs-0019R, Bioss Bio-
technology corporation, Beijing, China), Rabbit Anti-
Tenascin C antibody (bs-1039R, Bioss Biotechnology
corporation, Beijing, China), and Rabbit Anti-E-Selectin
antibody (bs-1273R, Bioss Biotechnology corporation,
Beijing, China). After rinsing with PBS, the specimens
were incubated with biotinylated secondary antibody
(ZSGB-BIO, Beijing, China) at room temperature for
20 min and then re-incubated with horseradish
peroxidase-labeled streptavidin for 20 min. The immu-
noreactivity was revealed by 3′diaminobenzidine (DAB)
solution and counterstained with hematoxylin. The pri-
mary antibody was omitted for the negative control.
Western blotting
Rats were killed under the deep anesthesia after five days
in the second hemorrhage. The BA, brain tissue, heart,
liver, kidney, lung, spleen, pancreas, spinal cord, thoracic
aorta, abdominal aorta, pulmonary artery and mesenteric
artery were isolated. The specimens were homogenized
in ice-cold extract buffer (PH = 7.4) and centrifuged at
20,000 rpm for 20 min at 4 °C. The protein concentra-
tion was determined by using a BCA kit (Thermo Fisher
Scientific, USA). Equal amounts of protein samples
(10 μg) were loaded on a tris glycine gel, separated by
12 % SDS-PAGE, electrophoresed, and transferred to a
polyvinylidencedifluoride (PVDF) membrane. Then, the
membrane was blocked with 5 % skimmed milk for 2 h
at room temperature, incubated overnight at 4 °C with
the Rabbit Anti-osteopontin antibody (bs-0019R, 1:200,
Bioss Biotechnology corporation, Beijing, China), Rabbit
Anti-Tenascin C antibody (bs-1039R, 1:200, Bioss
Biotechnology corporation, Beijing, China), and Rabbit
Anti-E-selectin antibody (bs-1273R, 1:200, Bioss Bio-
technology corporation, Beijing, China). GAPDH
(1:1000, Cell Signaling Technology, USA) was blotted on
the same membranes as a loading control. The
membrane was then incubated with goat anti-rabbit
horseradish peroxidase-conjugated secondary antibodies
(1:4000, ZSGB-BIO, Beijing, China) for 2 h at room
temperature. The immunoreactive bands were visualized
using an enhanced chemiluminescence method and
quantified with Image J software (NIH). Results were
expressed as a relative density to GAPDH.
Statistical analysis
The SPSS software package v 19.0 was used for all
analyses. Data expressed as mean ± standard deviation
(SD). The death rates were used in the chi-square test
for contrast. Differences between these means were eval-
uated by the one-way analysis of variance (ANOVA)
followed by the Student–Newman–Keuls (SNK) test for
multiple comparisons. *P <0.05 were considered statisti-
cally significant.
Results
CVS situation after SAH
Motality
The mortality rate of SD rats was 25 % (4 of 16) in SAH
group, none in sham group (0 in 12). There was no
significant difference were observed in the physiological
parameters (body weight, body temperature, pulse, blood
pressure and breathing) in the present study between
SAH and sham-operated rats or within the groups over
time.
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CVS after SAH in H&E staining
Morphological changes of BA in H & E staining were
shown in Fig. 1. The wall of normal control BA was
thinner, full of intima, uniform distribution of endothe-
lial cells with smooth internal elastic lamina and distrib-
uted with uniform and compact smooth muscle cells.
BA showed obvious contraction in SAH but not in the
sham group. And the wall of BA in SAH group became
thicker. Vascular endothelial cell nucleus chromatin of
cerebral vessel was aggregated, and internal elastic layer
was significantly corrugated. The distribution of cerebro-
vascular SMCs became sparse, and surrounded by red-
Fig. 1 Morphological changes of BA after SAH in H&E staining. a The sham group (n = 12) showed no appearance of vasospasm. b In SAH group
(n = 12), morphological changes of BA include narrowing of vessels, increased thickness of vascular wall, distorted of vascular endothelial cells and
crimped of internal elastic layer. scale bars = 50 μm
Fig. 2 Effects of a cisternal injection of blood on the diameter of basilar arteries in rats. a Representative angiograms of India ink; b Diameter of
BA on day 5 after second hemorrhage in both groups. Histograms of the diameter of BA showed significant decrease in SAH group compared
with that in sham group. Data are the means ± SEM (n = 12). *P < 0.05 versus normal BA
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Fig. 3 Representative immunohistochemical images of the expression of OPN, TNC and E-selectin in different tissues. (a), (b) and (c) respectively
represented TNC, OPN and E-selectin were expressed in different tissues and organs. In the pictures, (a) to (o) represented: (a) normal cerebral vessels;
(b) cerebral vessels on day 5 post-SAH; (c) brain tissue; (d) thoracic aorta; (e) abdominal aorta; (f) heart; (g) liver; (h) lungs; (i) kidney; (j) spinal cord; (k)
spleen; (l) pancreas; (m) retina; (n) mesenteric artery and (o) pulmonary artery. It showed that TNC had a wealth of expression in thoracic aorta and
abdominal aorta, however, low level of expression in spastic cerebral vessels. OPN in brain tissue, spinal cord, kidney, pancreas, mesenteric artery and
retina had obviously positive expression, this change also happened in spastic cerebral vessels after SAH. E-selectin and OPN had a similar region of
expression, but the difference was that E-selectin had a higher expression in spleen. scale bars = 20 μm
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Fig. 4 (See legend on next page.)
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stained tissue. The nucleus of cerebrovascular SMCs
were elongated, and internal elastic lamina were suffered
from edema and deterioration.
India ink angiography
India ink angiography after SAH showed the diameter of
BA in Fig. 2. The results suggested that contrast with
sham groups, the diameter of BA in SAH group was sig-
nificantly reduced.
OPN, TNC, E-selectin expressions different tissues after
SAH
Expression of OPN, TNC and E-selectin in tissues distribution
by immunohistochemical method
The expression of OPN, TNC and E-selectin in tissues and
organs were investigated by immunohistochemical method
showed in Fig. 3. These results indicated that TNC had a
wealth of expression in thoracic aorta and abdominal aorta,
however, low level of expression in spastic cerebral vessel. It
can not be considered as target recognition protein we
need. OPN in some tissues and organs (brain tissue, spinal
cord, kidney, pancreas, mesenteric artery and retina) had
obviously elevated expression, however, the expression of
which in spastic cerebral vessel after SAH was dramatically
increased compared with that in sham group. The distribu-
tion of expression of E-selectin in organs and tissues was
similar to OPN, but the level of expression of E-selectin
was lower than OPN, except for spleen.
Expression of OPN, TNC and E-selectin by western blot
The expression of OPN, TNC and E-selectin were also
investigated by western blot showed in Fig. 4. From the
chart, we can see that TNC in thoracic aorta and
abdominal aorta had obvious expression, and it was con-
sistent with the results of immunohistochemical method.
There were obviously postive expression of OPN but E-
selectin in some organs and tissues (brain tissue, spinal
cord, kidney, pancreas, mesenteric artery and retina),
however, the expression of OPN was observably elevated
in spastic cerebral vessels after SAH. On the other hand,
the positive expression of E-selectin was detected in
spleen.
Discussion
Currently, there are many kinds of treatments for CVS
after SAH [13–21]. However, these methods can only
reduce a part of occurrence of CVS [22]. Our previous
studies have showed that specific knocking down Cx43
in spastic cerebral arteries with specific siRNA interfer-
ence can significantly alleviate CVS after SAH. On the
basis of this, we mainly aimed at screening of a specific
high expression of protein as a recognition target in
spastic cerebral vessels, and achieve the goal of targeted
therapy for CVS.
Some studies have showed that the pathological
process of CVS after SAH was relevant to cerebrovascu-
lar inflammatory response [3, 23]. OPN and TNC are
mainly located in cytoplasm and extracellular matrix [8].
Studies indicated that the expression of these proteins
elevated during inflammation. E-selectin is mainly lo-
cated in vascular endothelial cells, and the expression of
which can be obviously induced by inflammatory cyto-
kine especially in cerebrovascular endothelial cells. How-
ever, the serum concentration of which will not up-
regulate at all [11].
From the results of this study, we confirmed that the
expression of OPN, TNC and E-selectin in normal cere-
bral vessel are in low level. However, the expression of
them markedly increased in spastic cerebral vessels after
SAH. They were in accord with the basic requirement of
being target recognition protein.
For the next study, we found that the expression of
TNC, but not OPN and E-selectin, extremely up-
regulated in aorta system (such as thoracic and abdom-
inal aorta). So we considered that TNC might not be
suitable as a target recognition protein. And the study of
it was stopped here.
Moreover, we have found that the expression of OPN
and E-selectin in some organs and tissues (including
brain tissue, kidney, pancreas, intimal layer of mesen-
teric artery, spinal cord and retina) were elevated. Other-
wise, the positive expression of E-selectin but OPN was
detected in spleen, however, there are still not too many
literatures show that Cx43 takes part in physiological
function of spleen. Therefore, we might choose E-
selectin as the best target recognition protein of these
proteins.
As we all know, cerebrovascular smooth muscle cells
(SMCs) are located in media layer of cerebral vessel wall.
In order to alleviate continuous contraction of SMCs in
cerebral vessels, the drug (carrying Cx43 siRNA or other
inhibitors) injected into blood needs to cross the intimal
(See figure on previous page.)
Fig. 4 Expressions of OPN, TNC and E-selectin in BA and other tissues. a represented the expression of OPN, TNC and E-selectin in BA measured
by western blot. In sham group (n = 12), SAH group (n = 12), c and e showed elevated expression of OPN, TNC and E-selectin in other tissues and
organs of the body. b, d and f were quantitative analysis of them. a and b showed that all of them had markedly increased in SMCs of spastic
cerebral arteries compared with control animals. c and d described that TNC had a high expression in thoracic aorta and abdominal aorta. e and
f showed that the level of OPN and E-selectin expression were significantly increased in brain tissue, spinal cord, kidney, pancreas, mesenteric
artery and retina, on the other hand, E-selectin had a high expression in spleen. Data are the means ± SEM (n = 12). *P < 0.05 versus normal BA
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layer. Under normal condition, vascular endothelial cells
are tightly connected with each other, so drugs can not
easily pass though the vascular endothelial cells. Fortu-
nately, when CVS occurs after SAH, cerebrovascular
endothelial cells and inner elastic layers are suffered
from obvious shrinkage or even necrosis [24]. The tight
junctions of cerebral vascular endothelial cells are sepa-
rated. That media layer of spastic cerebral vessels can be
exposed to the drug in blood. Meanwhile, highly
expressed target protein can be recognized by the drug
in blood, and Cx43 can be specific knocked down in
spastic cerebral vessel without affecting other organs
and tissues.
Some literatures find that kidney has a wealth ex-
pression of connexin, and they play a very important
role in regulating physiological function of kidney
[25]. The connexin is extremely important to main-
tain the physiological function of pancreatic islet cells
[26]. Vessels of these organs and tissues have normal
structure and function. The tight junction of vascular
endothelial cells can effectively prevent the drug from
invading into organs and tissues. In consequence, spe-
cifically recognized the target protein in spastic cere-
bral vessels can be considered to be a potential useful
method in treatment of CVS after SAH. And E-
selectin may be the best one of these proteins as tar-
get recognition protein.
Conclusion
The results of the this study showed that E-selectin may be
considered as target recognition proteins, however, OPN
and TNC may not be suitable as target recognition protein.
After we built the vehicle carrying Cx43 siRNA or other in-
hibitors, further research of E-selectin will be carried out.
Abbreviations
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